MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • 2018 International Congress

    Assessment of pain and its correlation with quality of life in Parkinson’s disease

    K. Anand, A. Agrawal, P. Kumar (New Delhi, India)

    Objective: The study was carried out to assess the prevalence of pain, nature of pain, quality of life and correlation of pain with quality of…
  • 2018 International Congress

    Effect of Urinary Dysfunction on Fatigue Syndrome in Parkinson’s disease

    V. Datieva, O. Levin (Moscow, Russian Federation)

    Objective: to investigate the relationship between urinary dysfunction and fatigue syndrome in Parkinson`s disease Background: Fatigue syndrome (FS) is an overwhelming sense of tiredness, lack…
  • 2018 International Congress

    Evolution of Motor and Non-Motor Manifestations in Prodromal Parkinsonism

    SM. Fereshtehnejad, C. Yao, A. Pelletier, J. Montplaisir, JF. Gagnon, R. Postuma (Montreal, QC, Canada)

    Objective: To trace the evolution of early motor and non-motor manifestations of synculeinopathy from the stage of idiopathic REM sleep behavior disorder (iRBD) until defined…
  • 2018 International Congress

    Relation of asymmetry of dopamine depletion with motor or non-motor symptoms in patients with Parkinson’s disease: A pilot study

    K.Y. Kwon, J.Y. Lee, K. Im (Seoul, Republic of Korea)

    Objective: This study was aimed to investigate whether asymmetry of dopamine depletion through dopamine transporter (DAT) imaging is associated with motor or non-motor symptoms in…
  • 2018 International Congress

    Factors Associated with Non-adherence to Pharmacotherapy in Patients with Parkinson´s Disease Who Take Three and More Daily Doses of Dopaminergic Drugs

    I. Straka, M. Škorvánek, M. Grofik, K. Danterová, M. Minár, J. Benetin, P. Valkovič (Bratislava, Slovakia)

    Objective: Study was aimed to detect extent of adherence to pharmacotherapy in patients with Parkinson´s disease (PD) who take three and more daily doses of…
  • 2018 International Congress

    Dyspnea in Parkinson’s disease: A biomarker of disease’s severity?

    G. Baille, T. Perez, F. Machuron, L. Defebvre, C. Chenivesse, C. Moreau (Lille, France)

    Objective: The aim of our study was to determine the prevalence of dyspnea in a monocentric cohort of 153 non-demented PD patients (mean age: 63.9…
  • 2018 International Congress

    The severity of motor symptoms and depression are the higher predictor for the decrease in daily living activities independence in people with Parkinson’s disease

    C. Dionizio Dias, E. Okamoto, C. Miranda, M. d'Alencar, M.E. Piemonte (São Paulo, Brazil)

    Objective: The purpose of this study was to identify among several motor, cognitive and mental measures which has higher power to predict the reduction in…
  • 2018 International Congress

    Prevalence of non-motor symptoms in Parkinson’s disease and its impact on quality of life in a tertiary care center in India

    M. Karri, B. Ramasamy, R. Kalidoss (Coimbatore, India)

    Objective: To study the prevalence of Non-Motor Symptoms (NMS) in Parkinson’s disease (PD) and their impact on health-related quality of life (HRQoL). Background: PD is…
  • 2018 International Congress

    Natural history of RBD in Parkinson´s disease and response to dopaminergic and non-dopaminergic antiparkinsonian treatment

    M. Ruiz-Lopez, V. Bruno, ME. Freitas, R. Rajalingam, A. Chang, S. Fox, A. Lang (Toronto, ON, Canada)

    Objective: To assess the natural history of rapid eye movement sleep behavior disorder (RBD) in patients with Parkinson´s disease (PD) and clarify its response to…
  • 2018 International Congress

    Alteration of the fecal microbiota in Chinese patients with Parkinson’s disease

    Y. Xiaodong, Q. Yiwei, X. Shaoqing, C. Shengdi, X. Qin (Shanghai, China)

    Objective: Emerging evidences suggest that gut microbiota dysbiosis plays a role in Parkinson’s disease (PD). However, the alterations in fecal microbiome in Chinese PD patients…
  • « Previous Page
  • 1
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • …
  • 55
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley